Neurosurgical Review

, Volume 9, Issue 4, pp 279–285 | Cite as

Treatment of cerebral arteriovenous malformation

  • Takashi Yoshimoto
  • Takamasa Kayama
  • Jiro Suzuki


The management of cerebral arteriovenous malformation (AVM) is discussed. A series of 231 cases of AVM was treated from 1961 to March 1984 in our department. The treatments of these cases are classified as total removal 169, partial removal 8, feeder clipping 14, embolization 4 and conservative 36. Results at discharge and at follow-up are analyzed and the treatments evaluated. At follow-up, no rebleeding is reported in the patients who had undergone extirpation. Cases treated with other methods showed rebleedings and either their condition worsened due to hemorrhages or they died. On the basis of these results, it is suggested that AVM should be extirpated totally. Our surgical procedure consisted of temporary occlusion of feeders using cerebral protective substances, so called “Sendai Cocktail” (mannitol, Vitamin E, steroid). This procedure makes complete surgery safe. Surgical results of the cases which were totally extirpated were better than those reported in previous reports: the mortality rate was 3,6%, and the morbidity rate was 5,4%. Because of this, surgical treatment was preferred, that is when the location, size of AVM, age, patient's circumstances and the surgeon's experience allow. However, there are still cases which must be treated with other therapy. These patients are withheld surgery because they have inaccessible AVM or large AVM etc., whose operation would cause neurological deficits. For the treatment of these cases we have recently attempt the chemical embolization method with conjugated estrogen. This produced good outcomes. These non-surgical treatments such as embolization and irradiation have still some unsolved problems and progress in the future is anticipated.


Arteriovenous malformation cerebral protective substances chemical embolization Sendai Cocktail surgical treatment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Debrun, G., F. Vinuela, A. Fox, et al.: Embolization of cerebral arteriovenous malformations with buccrylate. Experience in 46 cases. J. Neurosurg. 56 (1982) 613–627Google Scholar
  2. [2]
    Drake, C. G.: Cerebral arteriovenous malformations: Considerations for and experience with surgical treatment in 166 cases. Clin. Neurosurg. 26 (1979) 145–208Google Scholar
  3. [3]
    Fabrikant, J. I., J. T. Lyman, Y. Hosobuchi: Stereotactic heavyion bragg peak radiosurgery for intracranial vascular disorders: Method for treatment of deep arteriovenous malformations. Br. J. Radiol. 57 (1984) 479–490Google Scholar
  4. [4]
    Forster, D. M. C., L. Steiner, S. Hakanson: Arteriovenous malformations of the brain. A long term clinical study. J. Neurosurg. 37 (1972) 562–570Google Scholar
  5. [5]
    Imaizumi, S., T. Kayama, J. Suzuki: Chemiluminescence in hypoxic brain — The first report correlation between energy metabolism and free radical reaction. Stroke 15 (1984) 1061–1065Google Scholar
  6. [6]
    Kelly, P. J., G. J. Alker, J. G. Zoll: A microstereotaxic approach to deep-seated arteriovenous malformations. Surg. Neurol. 17 (1982) 260–262Google Scholar
  7. [7]
    Leksell, L.: Stereotaxic radiosurgery. J. Neurol. Neurosurg. Psychiatry 46 (1983) 797–803Google Scholar
  8. [8]
    Nagamine, Y., S. Komatsu, J. Suzuki: New embolization method using estrogen: Effect of estrogen on microcirculation. Surg. Neurol. 20 (1983) 269–275Google Scholar
  9. [9]
    Olivecrona, H., J. Ladenheim: Congenital arteriovenous aneurysms of the carotid and vertebral arterial systems, pp. 91. Springer-Verlag, Berlin 1957Google Scholar
  10. [10]
    Sano, K., Y. Ueda, I. Saito: Subarachnoid hemorrhage in children. Child's Brain 4 (1978) 38–46Google Scholar
  11. [11]
    Spetzler, R. F., C. B. Wilson, P. Weinstein, et al.: Normal perfusion pressure breakthrough theory. Clin. Neurosurg. 25 (1978) 651–672Google Scholar
  12. [12]
    Steiner, L., L. Leksell, T. Greitz, et al.: Stereotaxic radiosurgery for cerebral arteriovenous malformation. Acta Chir. Scand. 138 (1972) 459–464Google Scholar
  13. [13]
    Suzuki, J., A. Takaku, S. Hori, et al.: “Keel form incision” a new approach to the cranial base. Shujutsu (Tokyo) 19 (1965) 595–604Google Scholar
  14. [14]
    Suzuki, J., T. Yoshimoto: The effect of mannitol in prolongation of permissible occlusion time of cerebral artery-clinical data of aneurysm surgery. Neurosurg. Rev. 1 (1979) 13–19Google Scholar
  15. [15]
    Suzuki, J., N. Kodama, M. Honma: New clip and flexible clip forceps for neurosurgery. In: Suzuki, J., (ed.): Cerebral Aneurysms, pp. 386–388. Neuron, Tokyo 1979Google Scholar
  16. [16]
    Suzuki, J., R. Kwak, Y. Okudaira: The safe time limit of temporary clamping of cerebral arteries in the direct surgical treatment of intracranial aneurysm under moderate hypothermia. Tohoku J. Exp. Med 127 (1979) 1–7Google Scholar
  17. [17]
    Suzuki, J., S. Komatsu: New embolization method using estrogen for dural arteriovenous malformation and meningioma. Surg. Neurol. 16 (1981) 438–442Google Scholar
  18. [18]
    Suzuki, J., T. Yoshimoto, N. Kodama, et al.: Development of a new therapeutic method for the acute period of brain infarction. Revascularization following administration of mannitol and perfluorochemicals -Preliminary report. Surg. Neurol. 17 (1982) 325–332Google Scholar
  19. [19]
    Suzuki, J., T. Onuma, T. Kayama: Surgical treatment of intracranial arteriovenous malformations. Neurol. Res. 4 (1982) 191–207Google Scholar
  20. [20]
    Suzuki, J., T. Yoshimoto, T. Kayama: Surgical treatment of middle cerebral artery aneurysm. J. Neurosurg. 61 (1984) 17–23Google Scholar
  21. [21]
    Suzuki, J., S. Fujimoto, K. Mizoi, et al.: The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 15 (1984) 672–679Google Scholar
  22. [22]
    Suzuki, J., A. Ogawa, T. Yoshimoto, et al.: Indication for surgery in the acute stage of cerebral infarction: The role of new cerebral protective drugs “Sendai Cocktail” and perfluorochemicals. In: Spetzler, R. F., et al. (eds.): Cerebral Revascularization for Stroke, pp. 392–396. Thieme-Stratton, New York 1985Google Scholar
  23. [23]
    Suzuki, J., S. Imaizumi, T. Kayama: Chemiluminescence in hypoxic brain. The second report: Cerebral protective effect of mannitol, vitamin E and glucocorticoid. Stroke 16 (1985) 695–700Google Scholar
  24. [24]
    Suzuki, J., Y. Nagamine, A. Takahashi: New embolization method for inoperative AVMs and vascular rich tumors — Chemical embolization using conjugated estrogen. International Symposium on Surgery in and around the Brain Stem and the Third Ventricle, Hannover, Fed. Rep. Germany, February 20, 1985Google Scholar
  25. [25]
    Suzuki, J., A. Takahashi, T. Yoshimoto, et al.: Use of balloon occlusion and substances to protect ischemic brain during resection of posterior fossa AVM. J. Neurosurg. 63 (1985) 626–629Google Scholar
  26. [26]
    Suzuki, J., T. Yoshimoto, T. Kayama, et al.: Surgical treatment of intracranial arteriovenous malformation in children — a study of 42 cases -. Acta Neurochir. (submitted for publication)Google Scholar
  27. [27]
    Svien, H. J., J. A. Mcrae: Arteriovenous anomalies of the brain. Fate of patients not having definite surgery. J. Neurosurg. 23 (1965) 23–28Google Scholar
  28. [28]
    Yoshimoto, T., T. Sakamoto, T. Watanabe, et al.: Experimental cerebral infarction. Part 3: Protective effect of mannitol in thalamic infarction in dogs. Stroke 9 (1978) 217–218Google Scholar

Copyright information

© Walter de Gruyter & Co. 1986

Authors and Affiliations

  • Takashi Yoshimoto
    • 1
  • Takamasa Kayama
    • 1
  • Jiro Suzuki
    • 1
  1. 1.Division of Neurosurgery Institute of Brain DiseasesTohoku University School of MedicineSendaiJapan

Personalised recommendations